Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Early-life viral infection generates pathological tissue-resident memory cells that contribute to asthma-like disease
Emma E. Brown, Jie Lan, Olivia B. Parks, Li Fan, Dequan Lou, Alysia McCray, Lisa Mathews, Alexander J. Wardropper, Anna Shull, Michelle L. Manni, Heth R. Turnquist, Kong Chen, Taylor Eddens
Emma E. Brown, Jie Lan, Olivia B. Parks, Li Fan, Dequan Lou, Alysia McCray, Lisa Mathews, Alexander J. Wardropper, Anna Shull, Michelle L. Manni, Heth R. Turnquist, Kong Chen, Taylor Eddens
View: Text | PDF
Research Article Immunology Infectious disease Pulmonology

Early-life viral infection generates pathological tissue-resident memory cells that contribute to asthma-like disease

  • Text
  • PDF
Abstract

Viral lower respiratory tract infections are common early in life and are associated with long-term development of asthma, a chronic condition defined by reversible airflow obstruction secondary to inflammation. Understanding the immunological mechanism connecting these two pathologies observed early in life becomes imperative to guide therapeutic measures. To investigate this connection, neonatal (days 4–6) or adult mice were infected with human metapneumovirus (HMPV) followed by a secondary HMPV infection 6 weeks later. Mice initially infected as neonates demonstrated increased mucus production, eosinophil recruitment, airway hyperresponsiveness, and Th2 T cell differentiation after rechallenge compared with adult mice rechallenged with HMPV. Neonatal HMPV infection led to formation of Th2 clonally expanded tissue-resident memory (TRM) T cells that were absent after adult HMPV. FTY720-mediated disruption of lymphocyte circulation demonstrated that TRMs contributed to pathology. Local depletion of lung CD4+ T cells and JAK2 inhibition mitigated pathology. These findings suggest TRMs uniquely generated after early-life viral infection can contribute to Th2-driven asthma pathology.

Authors

Emma E. Brown, Jie Lan, Olivia B. Parks, Li Fan, Dequan Lou, Alysia McCray, Lisa Mathews, Alexander J. Wardropper, Anna Shull, Michelle L. Manni, Heth R. Turnquist, Kong Chen, Taylor Eddens

×

Figure 7

Early JAK2 inhibition reduces asthma pathology.

Options: View larger image (or click on image) Download as PowerPoint
Early JAK2 inhibition reduces asthma pathology.
(A) UMAP visualization o...
(A) UMAP visualization of Jak2 expression, showing upregulation in green circle corresponding to the Th2 cluster. (B) Mice were treated with fedratinib (120 mg/kg) once prior to rechallenge followed by BID dosing for the first 4 days after rechallenge. DMSO was used for vehicle control treatment. Created with BioRender.com. (C) Weight changes after rechallenge with HMPV. (D) Quantification of eosinophils 7 days after rechallenge. *P < 0.05 by Mann-Whitney U test. (E) N217-specific IL-4 and IFN-γ production after HMPV rechallenge, with a trend (P = 0.09, 2-tailed Student’s t test) toward reduced IL-4 production in JAK2i-treated mice. (F and G) IL-4, IL-5, IL-13, IL-2, IFN-γ, and GM-CSF protein quantity from whole lung homogenate. (H) Representative images of PAS staining demonstrating mucus production in large airways with reduction in JAK2i. Scale bar: 250 μm. (I) Quantification of PAS+ staining as percentage of total cell detections (left) and lung area (right). *P < 0.05 by 2-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts